BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 181702)

  • 41. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 42. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP; Jones MA; Marean AR; Bernstein MR
    Cancer; 1980 Feb; 45(3):423-6. PubMed ID: 6243507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Trophoblastic diseases].
    ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Trophoblastic disease. Its chemotherapy].
    Dinh-Van-Tung ; Mai-Van-Tuan
    J Gynecol Obstet Biol Reprod (Paris); 1972 Jun; 1(4):367-71. PubMed ID: 4343171
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease.
    Weed JC; Barnard DE; Currie JL; Clayton LA; Hammond CB
    Obstet Gynecol; 1982 Mar; 59(3):377-80. PubMed ID: 6176924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
    Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
    Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy after chemotherapy for gestational trophoblastic disease.
    Ayhan A; Ergeneli MH; Yüce K; Yapar EG; Kişnişçi AH
    J Reprod Med; 1990 May; 35(5):522-4. PubMed ID: 2161928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent gestational trophoblastic tumor after partial hydatidiform mole.
    Rice LW; Berkowitz RS; Lage JM; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Mar; 36(3):358-62. PubMed ID: 2156765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of gestational trophoblastic tumors.
    Hansen LA; Clayton BD
    Drug Intell Clin Pharm; 1984; 18(7-8):569-76. PubMed ID: 6086260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Worldwide controversies in gestational trophoblastic neoplasms.
    Goldstein DP
    Int J Gynaecol Obstet; 1977; 15(3):207-15. PubMed ID: 205453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of gestational trophoblastic disease.
    Jones WB; Lewis JL
    Am J Obstet Gynecol; 1974 Sep; 120(1):14-20. PubMed ID: 4367311
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole.
    Kim DS; Moon H; Kim KT; Moon YJ; Hwang YY
    Obstet Gynecol; 1986 May; 67(5):690-4. PubMed ID: 3008055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The chemotherapy of gestational trophoblastic disease: principles of clinical management.
    Goldstein DP
    JAMA; 1972 Apr; 220(2):209-13. PubMed ID: 4334308
    [No Abstract]   [Full Text] [Related]  

  • 59. A case of twin pregnancy with complete hydatidiform mole and coexisting fetus following IVF-ET.
    Kwon HE; Park EJ; Kim SH; Chae HD; Won HS; Kim CH; Kang BM
    J Assist Reprod Genet; 2002 Mar; 19(3):144-8. PubMed ID: 12005310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.